ARTICLE | Company News
Omthera submits Epanova NDA
July 10, 2013 12:15 AM UTC
Omthera Pharmaceuticals Inc. (NASDAQ:OMTH) submitted an NDA to FDA for Epanova to treat severe hypertriglyceridemia, defined as triglyceride levels greater than or equal to 500 mg/dL. Epanova is an ul...